期刊文献+

表达鸡新城疫病毒血凝素-神经氨酸酶基因的重组腺病毒对肝癌细胞HepG-2的抑制作用 被引量:6

Inhibitory Effect of Recombinant Adenovirus Expressing Hemagglutinin-Neuramidinase Gene of Newcastle Disease Virus on Hepatoma HepG-2 Cells
原文传递
导出
摘要 目的探讨表达鸡新城疫病毒(NDV)血凝素-神经氨酸酶(HN)基因的重组腺病毒Ad-HN对人肝癌细胞HepG-2的抑制作用。方法应用Ad-HN感染HepG-2细胞,采用MTT法检测Ad-HN对HepG-2细胞增殖的抑制作用;AnnexinV染色法结合流式细胞仪检测细胞凋亡;AO/EB染色法和DAPI染色法对Ad-HN感染的肿瘤细胞及细胞核进行形态学观察;底物显色法检测Caspase1、Caspase3、Caspase6和Caspase8活性的变化。结果Ad-HN能够有效抑制HepG-2细胞的增殖,当感染剂量为100MOI,作用时间为48h时,Ad-HN对HepG-2细胞增殖的抑制率达峰值(17.20%~35.04%);AnnexinV染色结果显示,Ad-HN感染48h后HepG-2细胞凋亡率为29.39%;Ad-HN感染导致HepG-2细胞呈现细胞浓缩、细胞核皱缩进而碎裂等凋亡特征;Ad-HN感染可显著上调HepG-2细胞的Caspase酶活性。结论Ad-HN能够诱导HepG-2细胞凋亡,并对HepG-2细胞产生抑制效应。 Objective To investigate the inhibitory effect of recombinant adenovirus Ad-HN expressing hemagglutinin(HA)neuramidinase(NA)gene of Newcastle disease virus (NDV)on human hepatoma HepG-2 cells. Methods HepG-2 cells were infected with Ad-HN, and the inhibitory effect of Ad-HN on proliferation of HepG-2 cells was determined by MTT method. The apoptosis of HepG-2 cells was determined by Annexin V staining combined with flow cytometry. The morphologies of HepG-2 cells infected with Ad-HN and their nuclei were observed by AO / EB staining and DAPI staining. The activities of Caspase 1, 3, 6 and 8 were determined by substrate coloration. Results Ad-HN inhibited the proliferation of HepG-2 cells effectively. After infection with Ad-HN at a MOI of 100 for 48 h, the inhibition rate of HepG-2 cells reached a peak value of 17. 20% ~ 35. 04%. Annexin V staining showed that the apoptosis rate of HepG-2 cells 48 h after infection with Ad-HN was 29. 39%. The infection with Ad-HN induced the apoptotic character of HepG-2 cells, such as cell condensation as well as nuclear shrinkage and breakage. Meanwhile, the infection with Ad-HN significantly up-regulated the Caspase activity of HepG-2 cells. Conclusion Ad-HN induced the apoptosis of and showed inhibitory effect on HepG-2 cells.
出处 《中国生物制品学杂志》 CAS CSCD 2010年第4期350-353,共4页 Chinese Journal of Biologicals
基金 国家高技术发展计划(863计划 2007AA021004)
关键词 新城疫病毒 血凝素-神经氨酸酶基因 重组腺病毒 肝癌 抗肿瘤作用 Newcastle disease virus(NDV) Hemagglutinin(HA)-neuramidinase(NA)gene Recombinant adenovirus Hepatoma Antitumor effect
  • 相关文献

参考文献3

二级参考文献15

  • 1李霄,金宁一,连海,管国芳,孙丽丽,李雪梅,郑洪玲.表达新城疫病毒血凝素-神经氨酸酶基因重组禽痘病毒的构建及其抑瘤作用[J].科学通报,2006,51(19):2252-2257. 被引量:5
  • 2Kim D H, McCormick F. Replicating viruses as selective cancer therapeutics[J]. Mol Med Today, 1996;2(12) :519-527.
  • 3Csatary L K, Moss R W, Beuth J et al. Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H) [J]. Anticancer Res, 1999; 19:635-638.
  • 4Bernt K M,Ni S,Tieu A T et al. Assessment of a combined adenovirusmediated oncolytic and immunos-timulatory tumor therapy [ J ]. Cancer Res,2005 ;65(10) :4343-4352.
  • 5Anderson R D,Haskell R E,Xia H et al.A simple method for the rapid generation of recombinant adenovirus vectors[J].Gene Ther, 2000; 7: 1034-1038.
  • 6Fiola C, Peeters B, Foumier P et ol. Tumor selective replication of Newcastle disease virus: Association with defects of tumor cells in an riviral defence[J]. Int J Cancer,2006; 119(2) :328-338.
  • 7Reiehard K W, Lorenee R M, Cassino C J et al. Selective replication of Newcastle disease virus(NDV)in cancer cells is associated with virus-induced cell fusion [ J ]. Proc Am Assoc Cancer Res, 1992; 33 : 521-525.
  • 8SambrookJ FritschEF ManiatisT 金冬雁 黎孟枫 译.分子克隆实验指南[M] 第2版[M].北京:科学出版社,1992..
  • 9Csatary LK, Moss RW, Beuth J, et al. Beneficial treatment of patients with advanced cancer using a newcastle disease virus vaccine(MTH-68/H).Anticancer Res, 1999,19:635-638.
  • 10Pecora AL,Rizvi N,Cohen GI,et al. Phase Ⅰ trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers. J Clin Oncol,2002,20:2220-2222.

共引文献11

同被引文献54

  • 1赵志龙,宗志红,李建新,刘宏旭,赵惠儒.从石蜡包埋肺癌组织提取RNA检测PML基因转录的研究[J].中国肺癌杂志,2008,11(4):563-566. 被引量:6
  • 2陈清,俞守义,申洪,王雅贤,吴敏.产毒性大肠杆菌的致病机制[J].第一军医大学学报,2003,23(8):826-829. 被引量:13
  • 3刘馨,张光明,李鸿钊,谢天宏,孙茂盛.表达轮状病毒VP4抗原的重组腺病毒对新生小鼠的被动免疫保护作用[J].中国生物制品学杂志,2007,20(1):33-36. 被引量:8
  • 4金天明,武迎红.腺病毒及腺病毒载体的研究进展[J].天津农学院学报,2007,14(2):48-51. 被引量:5
  • 5Tellinghuisen TL, Evans M J, Von Hahn T, et al. Studying hepatitis C virus: making the best of a bad virus[J]. J Virol, 2007, 81 (17): 8853-8867.
  • 6He TC, Zhou S, Da Costa LT, et al. A simplified system for generating recombinant adenoviruses [J]. Proc Natl Acad Sci USA, 1998, 95 (5): 2509-2514.
  • 7Del Porto P, Puntoriero G, Scatta C, et al. High prevalence of hypervariable region 1-specific and-cross-reactive CD4 (+) T cells in HCV-infected individuals responsive to IFN-alpha treatment [J]. Virology, 2000, 269 (2): 313-324.
  • 8Scotta C, Garbuglia AR, Ruggeri L, et al. Influence of specific CD4+T cells and antibodies on evolution of hypervariable region I during acute HCV infection [J]. J Hepatol, 2008, 48 (2): 216-228.
  • 9Burioni R, Mancini N, Carletti S, et al. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection [J]. Virology, 2004, 327 (2): 242-248.
  • 10Meunier JC, Engle RE, Faulk K, et al. Evidence fur cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1 [J]. Proc Natl Acad Sci USA, 2005, 102 ( 12): 4560-4565.

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部